Drug Price Reform Concerns Novartis Pharma President Tschudin
Part 2 Of An Interview With Novartis's Marie-France Tschudin
"We are definitely worried," Tschudin said about some US drug price reform proposals. She also spoke with Scrip about competitive rebating and new growth opportunities for anchor brands.
